Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Immune Response to SARS-CoV-2/COVID-19 Vaccination in Patients With Sarcoidosis

NCT05089565 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05089565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05089565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Immune Response to SARS-CoV-2/COVID-19 Vaccination in Patients With Sarcoidosis
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
December 31, 2022
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis, sars-cov2 infection, vaccine response impaired